The abstract is read at the publisher; the summary is JClub's.
An AI-guided three-biomarker panel on a micro-ChromaDot array distinguishes systemic lupus erythematosus (SLE) patients from healthy controls with 97% specificity and 93% sensitivity.
- Why it matters: Single biomarkers and lab-dependent assays are insufficient for complex chronic disease assessment, and point-of-care or home testing needs multiplex measurement plus automated analysis.
- What they did: The team used a chem-spatial signal-amplification cascade to read five biomarkers from a 3D microneedle array via smartphone imaging, then trained an SVM with 5-fold cross-validation to select the optimized panel.
- The result: A miniDia device with an App automated the McDa assay and smartphone analysis, achieving sensitivity superior to conventional ELISA for decentralized testing.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.